Revelyx Bio
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- Undisclosed
Investors
- 1
About Revelyx Bio
Founded in 2025 and based in Ohio, US, Revelyx Bio Inc. operates as a biotech company developing liquid botulinum toxin products for cosmetic and medical use. In January 2026, Revelyx Bio Inc. Revelyx Bio specializing in next-generation botulinum toxin therapies designed for aesthetic and medical applications. The firm develops botulinum toxin type A liquid formulation (pipeline: 003) engineered for higher efficacy, lower immunogenicity, improved resistance profiles, and greater precision, offering a more user-friendly alternative to traditional toxin products.
Who invested in Revelyx Bio
1 investor across 1 round
See all investors in Revelyx Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 9, 2026
Amount
Undisclosed
Investors
Questions about Revelyx Bio
Who invested in Revelyx Bio?
Revelyx Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Revelyx Bio raised?
Revelyx Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Revelyx Bio last raise money?
Revelyx Bio's most recent round on record is a Series A, in Jan 2026.
What does Revelyx Bio do?
Founded in 2025 and based in Ohio, US, Revelyx Bio Inc.
Where is Revelyx Bio headquartered?
Revelyx Bio is headquartered in Delaware, US.
Which VCs invest in companies like Revelyx Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back companies at Revelyx Bio's stage. Their profiles are linked below.
VCs to look at next
Raising like Revelyx Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.